Authors

Addressing Polypharmacy Challenges in Europe with Real World Evidence

A multi-national study reveals over half of older adults in several European countries are prescribed five or more medications—spotlighting the urgent need for better data-driven prescribing strategies.

How DSCSA Compliance Is Unlocking Recall Efficiency

In the final part of his Pharma Commerce video interview, Dan Walles, VP & GM, traceability and compliance solutions, TraceLink, notes that while DSCSA was designed for compliance, its first major business value is enabling targeted recalls.

HDA 2025 Traceability Seminar: DSCSA Compliance Ushers in a More Secure and Transparent Pharma Supply Chain

Kala Shankle, JD, HDA’s vice president of regulatory affairs, shares that as DSCSA traceability requirements take full effect, distributors and trading partners are preparing for long-term gains in supply chain security, recall efficiency, and counterfeit prevention.

Omnichannel, Evolved: Redefining the Model for Modern Pharma Marketing

Pharma must align data, personalization, and cross-functional orchestration to deliver human-centered experiences that connect with patients, HCPs, and caregivers alike.

Building Agility and Adaptability Into Pharma Operations

Why driving results from such strategies—amid industry disruption—will be critical to success.

Congress Revives Push to Digitize Prescription Information

New bipartisan legislation would give the FDA authority to modernize prescribing information, reducing waste while improving accuracy and patient care.

2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies

How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins

AI-powered control towers and digital twins are emerging as essential tools to prevent costly supply chain failures and restore operational reliability.

Building Agility and Adaptability Into Pharma Operations

Why driving results from such strategies—amid industry disruption—will be critical to success.

How AI-Powered Precision Is Reshaping Medical Affairs

Artificial intelligence is fundamentally transforming medical affairs from a reactive function into a strategic partner by converting disparate data into "precision medical affairs" insights, driving targeted HCP engagement and operational efficiency.

Trade & Channel Strategies 2025: Curatio's Priorities for Next Year

Cheryl Allen, BS Pharm, MBA, founding partner, highlights the coming year's focus on navigating an evolving regulatory landscape, while leveraging technology to track the pharmaceutical pipeline, assess analogs, and modernize distribution strategies.

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.

Forecasting the 2025 Healthcare Logistics Space

How will supply chains in the space continue to develop?

How Smart Packaging and Emerging AI Tools Are Shaping the Future of Cold Chain Integrity

In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, and Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explain how embedded product intelligence—paired with cautious, strategic adoption of AI—is redefining pharmaceutical cold chain reliability and supply-chain decision-making.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

Point of Care Lifts Reps Efforts

Point of Care and PatientPoint can improve the impact that your Pharma Reps are already having.

From Data Overload to Intelligent Commercialization: How Pharma Can Turn Connection Into Competitive Advantage

When intelligence flows across clinical, access, and engagement channels, commercialization shifts from reactive to predictive, giving teams the real-time edge to win in a fast-moving market.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

Monitoring Payer-Level Performance and Planning

Payer-level reporting should do more than track performance—it must guide strategy, focus resources, and drive measurable brand impact.

Fair Market Value vs. Current Market Leverage

How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services

Why Pharmaceutical Products Need Sustainable Packaging

One packaging aspect—the tape—is often overlooked, but is a valuable component of the shipping process.

Innovation with GenAI: Lessons from Life Sciences and Beyond

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Moving from Omnichannel to Optichannel Engagement Strategies: Your Questions Answered

Why the life science industry needs to move away from omnichannel marketing strategies and toward optichannel approaches that boost personalization and ROI in an era of shrinking budgets.

AI-Fueled Counterfeiting Surges as Pharma Confronts Rising Digital Threats

In a video interview with Pharma Commerce, Mark Lee, Marqvision’s founder and CEO, and Sean O’Hearen, founder and principal consultant at 1st Line Partners, warn that counterfeiters are rapidly leveraging AI to create fake websites, social profiles, and manipulated product content—outpacing traditional protections and highlighting widespread underreporting of falsified medicines.

Innovation with GenAI: Lessons from Life Sciences and Beyond

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Streamlining Clinical Trials with Site Augmentation

Imagine a world where clinical trials move seamlessly from concept to completion, staffing shortages are a thing of the past and patient recruitment happens at a record speed. Join Marken’s patient centric solutions expert and our featured guest for a dynamic discussion on how customizable site augmentation programs are accelerating life-saving treatments to market faster through scalable, flexible decentralized strategies. Learn practical solutions for streamlining on-site, remote or hybrid trials by matching dedicated clinical research professionals to your site’s unique needs, relieving staff burdens and empowering your team to focus on what matters most – patient care.

How Organizations Can Build a True Culture of Compliance

In final part of his Pharma Commerce video interview, Faisal Khan, a GRC solutions expert with Vanta, points out how leadership buy-in, role-based training, and “cyber moments” can reinforce continuous awareness and shared responsibility across the organization.